Inventor · disambiguated record
Thomas Kruse
Also filed as: KRUSE THOMAS · RICHTER BIRGIT · RICHTER LEGAL REPRESENTATIVE BIRGIT
40 granted patents·29 pending applications·247 citations·filing 1999–2024
97Inventor score
Top patents by PatentIndex Score
69 records- 0196US10005827B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2016·Granted Jun 26, 2018·24 cites·43 claims
- 0295US11117947B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2019·Granted Sep 14, 2021·7 cites·23 claims
- 0394US11034746B2Double-acylated GLP-1 derivativesNOVO NORDISK AS·Filed 2018·Granted Jun 15, 2021·6 cites·40 claims
- 0492US9006178B2Double-acylated GLP-1 derivatives with a linkerKOFOED JACOB·Filed 2011·Granted Apr 14, 2015·23 cites·26 claims
- 0591US9067977B2Peptides derivatized with A-B-C-D- and their therapeutical useNOVO NORDISK AS·Filed 2013·Granted Jun 30, 2015·18 cites·22 claims
- 0691US8575090B2Amylin analogues and pharmaceutical compositions thereofSCHAEFFER LAUGE·Filed 2012·Granted Nov 5, 2013·16 cites·11 claims
- 0790US8895694B2Glucagon-Like Peptide-1 derivatives and their pharmaceutical useSPETZLER JANE·Filed 2008·Granted Nov 25, 2014·29 cites·11 claims
- 0887US11767332B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2021·Granted Sep 26, 2023·1 cites·3 claims
- 0987US9023789B2Amylin analogs and pharmaceutical compositions thereofNOVO NORDISK AS·Filed 2013·Granted May 5, 2015·11 cites·14 claims
- 1086US11186595B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2018·Granted Nov 30, 2021·3 cites·13 claims
- 1186US9708383B2Double-acylated GLP-1 derivativesMADSEN ALICE RAVN·Filed 2011·Granted Jul 18, 2017·14 cites·16 claims
- 1285US8741836B2PolypeptidesSCHAEFFER LAUGE·Filed 2012·Granted Jun 3, 2014·7 cites·12 claims
- 1384US9409966B2Glucagon-like peptide-1 derivatives and their pharmaceutical useNOVO NORDISK AS·Filed 2014·Granted Aug 9, 2016·6 cites·22 claims
- 1484US8722849B2PolypeptidesSCHAEFFER LAUGE·Filed 2012·Granted May 13, 2014·6 cites·19 claims
- 1584US8541368B2Glucagon analoguesNOVO NORDISK AS·Filed 2012·Granted Sep 24, 2013·6 cites·41 claims
- 1684US8232242B2Treatment of inflammatory bowel diseases with mammal beta defensinsKJAER TANJA MARIA ROSENKILDE·Filed 2009·Granted Jul 31, 2012·6 cites·8 claims
- 1782US8232248B2Treatment of rheumatoid arthritis with mammal beta defensinsKJAER TANJA MARIA ROSENKILDE·Filed 2009·Granted Jul 31, 2012·6 cites·9 claims
- 1881US12227528B2Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2023·Granted Feb 18, 2025·0 cites·4 claims
- 1981US2025122226A1Glucose-sensitive albumin-binding derivativesNOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 2080US9593149B2Amylin and calcitonin receptor agonistNOVO NORDISK AS·Filed 2016·Granted Mar 14, 2017·3 cites·15 claims
- 2180US9279010B2Treatment of inflammatory bowel diseases with mammal beta defensinsDEFENSIN THERAPEUTICS APS·Filed 2014·Granted Mar 8, 2016·5 cites·21 claims
- 2279US8802621B2Treatment of inflammatory bowel diseases with mammal beta defensinsKJAER TANJA MARIA ROSENKILDE·Filed 2011·Granted Aug 12, 2014·4 cites·19 claims
- 2379US8575091B1Amylin analogues and pharmaceutical compositions thereofNOVO NORDISK AS·Filed 2013·Granted Nov 5, 2013·4 cites·13 claims
- 2478US8895504B2Amylin derivativesSCHÄFFER LAUGE·Filed 2009·Granted Nov 25, 2014·7 cites·11 claims
- 2577US12054528B2Co-agonists of the GLP-1 and amylin receptorsNOVO NORDISK AS·Filed 2022·Granted Aug 6, 2024·0 cites·24 claims
- 2677US9029325B2Amylin analogues and pharmaceutical compositions thereofNOVO NORDISK AS·Filed 2013·Granted May 12, 2015·2 cites·11 claims
- 2776US9486505B2Glucagon analoguesNOVO NORDISK AS·Filed 2013·Granted Nov 8, 2016·2 cites·23 claims
- 2874US9732137B2Semi-recombinant preparation of GLP-1 analoguesLAU JESPER FAERGEMAN·Filed 2008·Granted Aug 15, 2017·4 cites·11 claims
- 2974US8835604B2Antimicrobial peptide variants and polynucleotides encoding sameHOEGENHAUG HANS-HENRIK KRISTENSEN·Filed 2011·Granted Sep 16, 2014·2 cites·19 claims
- 3074US8835379B2Derivatives of CGRPNIELSEN ANETTE SAMS·Filed 2010·Granted Sep 16, 2014·6 cites·11 claims
- 3171US9486506B2Glucagon analoguesNOVO NORDISK AS·Filed 2015·Granted Nov 8, 2016·1 cites·17 claims
- 3270US6919315B1Compounds with growth hormone releasing propertiesNOVO NORDISK AS·Filed 1999·Granted Jul 19, 2005·17 cites·17 claims
- 3370US2024279299A1Co-agonists of the glp-1 and amylin receptorsNOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 3468US9988430B2Stable GLP-1 based GLP-1/glucagon receptor co-agonistsNOVO NORDISK AS·Filed 2015·Granted Jun 5, 2018·1 cites·29 claims
- 3564US2018016319A1Acylated Glucagon AnaloguesNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 3663US12116388B2Amylin receptor agonistsNOVO NORDISK AS·Filed 2023·Granted Oct 15, 2024·0 cites·15 claims
- 3763US2015031601A1Antimicrobial Peptide Variants and Polynucleotides Encoding SameADDENIUM BIOTECH AS·Filed 2014·Application pending·0 cites
- 3862US2017190757A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 3961US7576062B2Compounds with growth hormone releasing propertiesNOVO NORDISK AS·Filed 2005·Granted Aug 18, 2009·0 cites·15 claims
- 4061US2016271263A1Acylated Glucagon AnaloguesNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 4160US2017051034A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 4258US2015274801A1Acylated glucagon analoguesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 4358US2010261637A1Peptides derivatized with a-b-c-d- and their therapeutical useNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 4457US2013035285A1Novel glucagon analoguesNOVO NORDISK AS·Filed 2011·Application pending·0 cites
- 4557US2016002311A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 4657US2013143798A1Novel glucagon analoguesLAU JESPER F·Filed 2011·Application pending·0 cites
- 4754US9751927B2Stable, protracted GLP-1/glucagon receptor co-agonists for medical useNOVO NORDISK AS·Filed 2016·Granted Sep 5, 2017·0 cites·3 claims
- 4854US2012309678A1Treatment of Inflammatory Bowel Diseases With Mammal Beta DefensinsKJAER TANJA MARIA ROSENKILDE·Filed 2012·Application pending·0 cites
- 4954US2016347812A1Novel Glucagon AnaloguesNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 5054US2010317057A1Semi-recombinant preparation of glp-1 analoguesNOVO NORDISK AS·Filed 2007·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas Kruse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →